Insider Transactions in Q2 2021 at Karuna Therapeutics, Inc. (KRTX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2021
|
Heather Preston Director |
BUY
Other acquisition or disposition
|
Direct |
184
+2.73%
|
-
|
|
Jun 16
2021
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,600
-8.69%
|
$332,800
$128.92 P/Share
|
|
Jun 16
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+7.71%
|
$23,400
$9.2 P/Share
|
|
Jun 14
2021
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
900
-6.47%
|
$118,800
$132.52 P/Share
|
|
Jun 14
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+6.08%
|
$8,100
$9.2 P/Share
|
|
Jun 14
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
8,334
-15.48%
|
$1,091,754
$131.44 P/Share
|
|
Jun 14
2021
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+13.41%
|
$75,006
$9.2 P/Share
|
|
Jun 11
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
8,333
-15.48%
|
$1,074,957
$129.33 P/Share
|
|
Jun 11
2021
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+13.4%
|
$74,997
$9.2 P/Share
|
|
Jun 10
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
13,333
-22.66%
|
$1,639,959
$123.68 P/Share
|
|
Jun 10
2021
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
13,333
+18.48%
|
$119,997
$9.2 P/Share
|
|
Jun 07
2021
|
Laurie J Olson |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$448,000
$112.93 P/Share
|
|
Jun 07
2021
|
Laurie J Olson |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$336,000
$84.86 P/Share
|
|
Jun 01
2021
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$277,500
$111.44 P/Share
|
|
Jun 01
2021
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|
|
May 12
2021
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
200
-1.52%
|
$24,000
$120.0 P/Share
|
|
May 12
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+1.49%
|
$1,800
$9.2 P/Share
|
|
May 10
2021
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,000
-35.0%
|
$770,000
$110.07 P/Share
|
|
May 10
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+25.93%
|
$63,000
$9.2 P/Share
|
|
May 10
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-9.9%
|
$550,000
$110.43 P/Share
|
|
May 10
2021
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.01%
|
$45,000
$9.2 P/Share
|
|
May 03
2021
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$275,000
$110.61 P/Share
|
|
May 03
2021
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|
|
Apr 13
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
1,264
+25.0%
|
-
|
|
Apr 13
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
150,000
-4.9%
|
-
|
|
Apr 13
2021
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
1,756
+25.0%
|
-
|
|
Apr 13
2021
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
150,000
-4.9%
|
-
|
|
Apr 12
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-9.9%
|
$570,000
$114.22 P/Share
|
|
Apr 12
2021
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.01%
|
$45,000
$9.2 P/Share
|
|
Apr 01
2021
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$300,000
$120.01 P/Share
|
|
Apr 01
2021
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|